Latest News & Updates
Breaking News
12 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
PCI Pharma's $1B Bet Reshapes Sterile Fill-Finish Capacity
PCI Pharma Services commits $1B to injectable manufacturing and device assembly, reshaping CDMO capacity for sterile fill-finish.
Pharma Now Editorial Team
LAZCLUZE Combo Approval Raises the Bar for EGFR-Targeted Manufacturing
Janssen's LAZCLUZE approval as a dual-modality EGFR regimen sets new operational demands for oncology manufacturers and QA teams.
Pharma Now Editorial Team
NIKTIMVO Approval Raises Sterile Fill-Finish Bar for Rare Disease Biologics
Incyte's NIKTIMVO IV biologic approval for chronic GVHD sets a regulatory and manufacturing reference point for rare disease parenteral biologics.
Pharma Now Editorial Team
LIVDELZI Approval Sets New Regulatory Bar for PBC Therapies
Cymabay's LIVDELZI approval sets a regulatory and manufacturing reference for PPAR-delta agonists in rare liver disease submissions.
Pharma Now Editorial Team
